Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis

[1]  S. Franks,et al.  Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome , 1997, Clinical endocrinology.

[2]  M. McCarthy,et al.  Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome , 1997, The Lancet.

[3]  M. McCarthy,et al.  Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. , 1997, Human molecular genetics.

[4]  S. Franks.  The 17α‐hydroxylase/17,20 lyase gene (CYP17) and polycystic ovary syndrome , 1997 .

[5]  G. Conway,et al.  Frequency of a polymorphism in the regulatory region of the 17α‐hydroxylase‐17,20‐lyase (CYP17) gene in hyperandrogenic states , 1997, Clinical endocrinology.

[6]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[7]  L. Ibáñez,et al.  Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. , 1996, The Journal of clinical endocrinology and metabolism.

[8]  R. Williamson,et al.  5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. , 1996, The Journal of clinical endocrinology and metabolism.

[9]  S. Franks,et al.  Gonadotrophin and gonadal steroid response to a single dose of a long‐acting agonist of gonadotrophin‐releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome , 1995, Clinical endocrinology.

[10]  S. Franks,et al.  Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.

[11]  J. Little,et al.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.

[12]  S. Franks,et al.  Evidence for a single gene effect causing polycystic ovaries and male pattern baldness , 1993 .

[13]  D. Ehrmann,et al.  Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.

[14]  S. Franks.  The ubiquitous polycystic ovary. , 1991, The Journal of endocrinology.

[15]  A. Lucky,et al.  Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome , 1990 .

[16]  D. Ehrmann,et al.  Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. , 1989, The New England journal of medicine.

[17]  P. Magnus,et al.  Familial clustering in the polycystic ovarian syndrome. , 1989, Gynecologic and obstetric investigation.

[18]  S. Reeders,et al.  FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE? , 1988, Clinical endocrinology.

[19]  J. Givens.  Familial polycystic ovarian disease. , 1988, Endocrinology and metabolism clinics of North America.

[20]  D. de Ziegler,et al.  Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. , 1987, The Journal of clinical endocrinology and metabolism.

[21]  G. Schaison,et al.  Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease. , 1986, The Journal of clinical endocrinology and metabolism.

[22]  W. Vale,et al.  Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. , 1983, The Journal of clinical endocrinology and metabolism.

[23]  D. Ferriman,et al.  THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING , 1979, Clinical endocrinology.

[24]  H. E. Cooper,et al.  Hereditary factors in the Stein-Leventhal syndrome. , 1968, American journal of obstetrics and gynecology.